Revealed: which pharma companies leading the way in artificial intelligence

According to our analysis, Pfizer, Novartis, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Takeda, GSK, Bayer and Astellas Pharma are the companies best positioned to benefit from investments in artificial intelligence, all of them recording scores of five out of five in GlobalData’s Drug Development Thematic Scorecard.